Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ECG-I Targeted Ablation for Persistent AF Not Responding to Pulmonary Vein Isolation: Results of a Two Staged Strategy (ECG-I TARGET AF2)

NCT04633265 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.

NCT NCT04633265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04633265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ECG-I Targeted Ablation for Persistent AF Not Responding to Pulmonary Vein Isolation: Results of a Two Staged Strategy (ECG-I TARGET AF2)
Lead sponsor
Barts & The London NHS Trust
Phase
Not applicable
Overall status
Completed
Start date
January 10, 2018
Completion date
March 31, 2021
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation